Dr. Dario Rusciano completed his PhD in Cell and Molecular Biology from Pisa University, Italy, in 1979. He has been involved as a postdoc and project leader in basic research on the organ specificity of cancer metastasis at the Sclavo pharmaceutical company of Siena, Italy and then at the Friedrich Miescher Institute of Basel, Switzerland. He then shifted his interests toward translational research in ophthalmology, working as a lab leader at SIFI, a pharmaceutical company based in Sicily, Italy, and then at Sooft, another pharmaceutical company now owned by Fidia Pharmaceuticals, Italy, where he was appointed research director for ophthalmology. He has authored over 100 papers published in international refereed journals and one book on experimental approaches to cancer metastasis. He is now retired and works as a scientific consultant in ophthalmology and different scientific matters.
Research Keywords & Expertise
Drug Delivery
Ophthalmology
Eye diseases
presbyopia
Myopia
Ocular Surface Disorde...
retinal diseases
Fingerprints
6%
retinal diseases
5%
Eye diseases
5%
Myopia
5%
presbyopia
Short Biography
Dr. Dario Rusciano completed his PhD in Cell and Molecular Biology from Pisa University, Italy, in 1979. He has been involved as a postdoc and project leader in basic research on the organ specificity of cancer metastasis at the Sclavo pharmaceutical company of Siena, Italy and then at the Friedrich Miescher Institute of Basel, Switzerland. He then shifted his interests toward translational research in ophthalmology, working as a lab leader at SIFI, a pharmaceutical company based in Sicily, Italy, and then at Sooft, another pharmaceutical company now owned by Fidia Pharmaceuticals, Italy, where he was appointed research director for ophthalmology. He has authored over 100 papers published in international refereed journals and one book on experimental approaches to cancer metastasis. He is now retired and works as a scientific consultant in ophthalmology and different scientific matters.
Well done!
